This test provides limited information as to the HLA specificities of the antibodies. Detects antibodies of the IgG isotype and not IgM antibodies, which are usually indicative of …

Use to detect HLA antibodies for solid organ and stem cell transplantation. Indicates whether a test has been approved by the New York State Department of Health. Testing is not New York …

Donor-specific antibodies (DSA) are a concept in transplantation medicine and describe the presence of antibodies specific to the Donor's HLA-Molecules. These antibodies can cause …

The high specificity and sensitivity of this solid phase single antigen assay allows us to detect and identify low-levels of precise antibodies. The detection of antibodies in pre-transplant …

The ability to test for and track HLA Class I and Class II antibodies can provide early intervention for ABMR and graft failure. The routine monitoring of DSA in the post-transplant setting can …

Purpose of the test is to monitor patients after transplant for the presence and level of antibodies to the donor’s HLA antigens. The test is semi-quantitative.

This test is generally used by Clinicians to monitor post-transplant production of donor specific HLA antibodies following solid organ transplantation. Most local DSA testing is ordered by the …

Test Information: The purpose of this test is to monitor patients after transplant for the presence and level of antibodies to the donor’s HLA antigens. The test is semi-quantitative.

May 20, 2012 · While traditional markers can aid in diagnosing the clinical status of solid organ transplant recipients, they are generally non-specific and most often identifiable only after graft …

Jun 13, 2025 · DSA are detected using various laboratory techniques, including complement-dependent cytotoxicity, flow cytometry, solid-phase assays like Luminex, and ELISA. Regular …